Trial Profile
Clinical study evaluating the tolerability and pharmacokinetics of different formulations of lorcaserin extended-release tablets
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Mar 2014
Price :
$35
*
At a glance
- Drugs Lorcaserin (Primary)
- Indications Obesity
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Arena Pharmaceuticals
- 06 Mar 2014 New trial record